Literature DB >> 29179609

Staged pallidotomy: MRI and clinical follow-up in status dystonicus.

Angelo Franzini1, Vincenzo Levi1, Andrea Franzini1, Ivano Dones1, Giuseppe Messina1.   

Abstract

PURPOSE: We report on a patient affected by Status Distonicus who was treated with Deep Brain Stimulation electrodes implanted in the Globus Pallidus internus (Gpi) and used for serial radiofrequency lesions.
MATERIALS AND METHODS: The evolution of radiofrequency lesions was monitored by post-operative and late Magnetic Resonance Imaging (MRI). After the first lesion the patient did improve, though not in a significant fashion. Therefore, three further radiofrequency lesions were delivered 2, 4 and 6 days respectively after surgery with subsequent improvement of dystonic movements.
RESULTS: MRI scans performed at 8 days, 3 months, and 6 months after surgery showed a diffuse T2-hyperintense and T1-hypointense GPi signal alteration which progressively decreased over time.
CONCLUSION: We confirm that the possibility to stage pallidotomies over time using a couple of new contacts is a safe and efficacious procedure in treating SD patients where the lesions themselves are limited by the appearance of side effects, or in patients showing a poor response to a single lesion. As far as we know, this is the first description of MRI evolution and monitoring of a staged pallidotomy.

Entities:  

Keywords:  Staged pallidotomy; generalized dystonia; globus pallidus internus; status dystonicus

Mesh:

Year:  2017        PMID: 29179609     DOI: 10.1080/02688697.2017.1409875

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  Transcranial Magnetic Resonance-Guided Focused Ultrasound in X-Linked Dystonia-Parkinsonism.

Authors:  Roland Dominic G Jamora; Wei-Chieh Chang; Takaomi Taira
Journal:  Life (Basel)       Date:  2021-04-26

Review 2.  Bilateral Pallidotomy for Dystonia: A Systematic Review.

Authors:  Liesanne M Centen; D L Marinus Oterdoom; Marina A J Tijssen; Ivon Lesman-Leegte; Martje E van Egmond; J Marc C van Dijk
Journal:  Mov Disord       Date:  2020-11-20       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.